Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells

Bai Cui, Yuanyuan Luo, Pengfei Tian, Fei Peng, Jinxin Lu, Yongliang Yang, Qitong Su, Bing Liu, Jiachuan Yu, Xi Luo, Liu Yin, Wei Cheng, Fan An, Bin He, Dapeng Liang, Sijin Wu, Peng Chu, Luyao Song, Xinyu Liu, Huandong LuoJie Xu, Yujia Pan, Yang Wang, Dangsheng Li, Peng Huang, Qingkai Yang, Lingqiang Zhang, Binhua P. Zhou, Suling Liu, Guowang Xu, Eric W.F. Lam, Keith W. Kelley, Quentin Liu

Research output: Contribution to journalArticlepeer-review

202 Scopus citations

Abstract

Chronic stress triggers activation of the sympathetic nervous system and drives malignancy. Using an immunodeficient murine system, we showed that chronic stress–induced epinephrine promoted breast cancer stem-like properties via lactate dehydrogenase A–dependent (LDHA-dependent) metabolic rewiring. Chronic stress–induced epinephrine activated LDHA to generate lactate, and the adjusted pH directed USP28-mediated deubiquitination and stabilization of MYC. The SLUG promoter was then activated by MYC, which promoted development of breast cancer stem-like traits. Using a drug screen that targeted LDHA, we found that a chronic stress–induced cancer stem-like phenotype could be reversed by vitamin C. These findings demonstrated the critical importance of psychological factors in promoting stem-like properties in breast cancer cells. Thus, the LDHA-lowering agent vitamin C can be a potential approach for combating stress-associated breast cancer.

Original languageEnglish
Pages (from-to)1030-1046
Number of pages17
JournalJournal of Clinical Investigation
Volume129
Issue number3
DOIs
StatePublished - Mar 2019

Bibliographical note

Publisher Copyright:
2019 © American Society for Clinical Investigation. All Rights Reserved.

Funding

This research work was supported by the National Natural Science Foundation of China (81820108024 to QL;81630005 to QL; 81573025 to QL; and 81703091 to FA); the Science and Technology Planning Project of Guangzhou (201604020163 to QL); and the Dalian High-level Talent Innovation Program (2016RD12 to QL). EWFL\u2019s work is supported by the Medical Research Council (MRC) (MR/N012097/1); Cancer Research UK (CRUK) (C37/A12011; C37/ A18784); Breast Cancer Now (2012MayPR070; 2012NovPhD016); the CRUK Imperial Centre, Imperial Experimental Cancer Medicine Centre (ECMC); and the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC).

FundersFunder number
Medical Research Council Canada
Breast Cancer Now
NIHR Imperial Biomedical Research Centre
National Institute for Health Research Health Protection Research Unit
UK Industrial Decarbonization Research and Innovation Centre
Dalian High-level Talent Innovation Program2016RD12
Dalian High-level Talent Innovation Program
Yorkshire Cancer Research/Cancer Research UK Sheffield Cancer CentreC37/A12011, C37/ A18784, A18784
Yorkshire Cancer Research/Cancer Research UK Sheffield Cancer Centre
Breast Cancer Now2012NovPhD016, 2012MayPR070
Breast Cancer Now
National Natural Science Foundation of China (NSFC)81630005, 81820108024, 81573025, 81703091
National Natural Science Foundation of China (NSFC)
Medical Research Council-São Paulo Research FoundationMR/N012097/1
Medical Research Council-São Paulo Research Foundation
Guangzhou Municipal Science and Technology Project201604020163
Guangzhou Municipal Science and Technology Project

    ASJC Scopus subject areas

    • General Medicine

    Fingerprint

    Dive into the research topics of 'Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells'. Together they form a unique fingerprint.

    Cite this